Contact this trialFirst, we need to learn more about you.
Chemotherapy
Gemtuzumab + Midostaurin for Acute Myeloid Leukemia
Recruiting1 awardPhase 1
Columbus, Ohio
This trial is testing a new combination of two drugs, gemtuzumab ozogamicin and midostaurin, to see if it is safe and tolerable in patients with newly diagnosed FLT3-mutated Acute Myeloid Leukemia (AML).
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.